|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.65 USD | +2.66% |
|
-0.39% | +132.25% |
EPS & Dividend: Protagonist Therapeutics, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.92 | -2.71 | -2.6 | -1.39 | 4.23 | -1.595 | 0.9959 | -1.284 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 20.16 | 34.20 | 10.91 | 22.93 | 38.60 | 89.65 | 89.65 | 89.65 |
| Nbr of stocks (in thousands) | 43,019 | 47,728 | 49,198 | 57,678 | 59,598 | 62,516 | - | - |
| Announcement Date | 3/10/21 | 2/28/22 | 3/15/23 | 2/27/24 | 2/21/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Protagonist Therapeutics, Inc.
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | -56.22x | - | 81.07x | |
| 0.92% | 1.04% | 37.75x | 3.89x | 5.5x | |
| -.--% | -.--% | 31.8x | 6.06x | 3.2x | |
| -.--% | -.--% | 103.74x | 8.94x | 6.32x | |
| 0.4% | 0.43% | 51.48x | 2.28x | 9.93x | |
| -.--% | -.--% | 37.03x | 36.97x | 5.99x | |
| -.--% | -.--% | -14.27x | 9.7x | 5565.23x | |
| -.--% | -.--% | 28.78x | 1.52x | 2.13x | |
| -.--% | -.--% | -51.58x | 33.61x | 11.12x | |
| -.--% | -.--% | -36.27x | 48.05x | 13.75x | |
| Average | 0.15% | 0.16% | 13.22x | 16.78x | 570.42x | |
| Weighted average by Cap. | 0.25% | 0.28% | 32.62x | 11.94x | 386.54x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition